Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.
Mardiguian S, Serres S, Ladds E, Campbell SJ, Wilainam P, McFadyen C, McAteer M, Choudhury RP, Smith P, Saunders F, Watt G, Sibson NR, Anthony DC. Mardiguian S, et al. Among authors: ladds e. Am J Pathol. 2013 Jun;182(6):2071-81. doi: 10.1016/j.ajpath.2013.02.029. Epub 2013 Apr 16. Am J Pathol. 2013. PMID: 23602647 Free PMC article.
Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
Halford S, Wan S, Dragoni I, Silvester J, Nazarov B, Anthony D, Anthony S, Ladds E, Norrie J, Dhaliwal K; and the CDD SPIKE-1 Project Team. Halford S, et al. Among authors: ladds e. Trials. 2022 Apr 21;23(1):336. doi: 10.1186/s13063-022-06266-0. Trials. 2022. PMID: 35449061 Free PMC article. No abstract available.
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
Halford S, Wan S, Dragoni I, Silvester J, Nazarov B, Anthony D, Anthony S, Ladds E, Norrie J, Dhaliwal K; CDD SPIKE-1 Project Team. Halford S, et al. Among authors: ladds e. Trials. 2021 Aug 19;22(1):550. doi: 10.1186/s13063-021-05461-9. Trials. 2021. PMID: 34412682 Free PMC article.
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia.
Noel-Storr AH, Flicker L, Ritchie CW, Nguyen GH, Gupta T, Wood P, Walton J, Desai M, Solomon DF, Molena E, Worrall R, Hayen A, Choudhary P, Ladds E, Lanctôt KL, Verhey FR, McCleery JM, Mead GE, Clare L, Fioravanti M, Hyde C, Marcus S, McShane R. Noel-Storr AH, et al. Among authors: ladds e. Alzheimers Dement. 2013 May;9(3):e96-e105. doi: 10.1016/j.jalz.2012.01.014. Epub 2012 Oct 27. Alzheimers Dement. 2013. PMID: 23110863 Review.
Long Covid - The illness narratives.
Rushforth A, Ladds E, Wieringa S, Taylor S, Husain L, Greenhalgh T. Rushforth A, et al. Among authors: ladds e. Soc Sci Med. 2021 Oct;286:114326. doi: 10.1016/j.socscimed.2021.114326. Epub 2021 Aug 19. Soc Sci Med. 2021. PMID: 34425522 Free article.
40 results